DHR-Sponsored Training Programme at ICMR-CRMCH Week 2 – Day 4 – ICMR-NIRBID
ICMR-NIRBID shared a post on LinkedIn:
“Week 2 – Day 4 Highlights | DHR-Sponsored Training Programme at ICMR-CRMCH, Chandrapur
The ongoing DHR-sponsored 4-week training programme at ICMR-CRMCH, Chandrapur, continued with expert sessions covering therapeutic advances, patient management, and translational research in haemoglobinopathies.
- Dr. Nita Radhakrishnan, Additional Professor and Head, PGICH, Noida, delivered an insightful online session on Hydroxyurea Therapy for Sickle Cell Disease, discussing current evidence, treatment protocols, and its impact on improving clinical outcomes.
- Dr. Atish Bakane, Haematologist, Nagpur, conducted comprehensive sessions on Advanced Treatment Strategies for Haemoglobinopathies, including Hematopoietic Stem Cell Transplantation (HSCT)/Bone Marrow Transplantation (BMT), along with evidence-based approaches to Pain Management in Sickle Cell Disease.
- Dr. Rikesh K. Dubey, SRM University, presented an engaging lecture on Studying Sickle Cell Disease Using Animal Models, highlighting the role of experimental models in advancing our understanding of disease pathophysiology and therapeutic development.
Together, these sessions offered participants valuable insights into the continuum of haemoglobinopathy research—from laboratory models and translational science to advanced clinical management and curative therapies.”
Nita Radhakrishnan, Additional Professor and HOD of Pediatric Hematology-Oncology at Post Graduate Institute of Child Health, shared ICMR-NIRBID’s post on LinkedIn:
“Precision medicine is redefining hemoglobinopathy care—from optimized hydroxy urea in sickle cell disease to curative HSCT and future targeted therapies.
Happy to contribute”
Stay updated with Hemostasis Today.
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target
-
Oct 7, 2026, 15:28Amir Samimi: Prognostic Value of Platelet Count in Resected HNSCC
-
Oct 7, 2026, 15:21Eloïse Laouenan: Bridging Immunity and Thrombosis in MVTE
-
Oct 7, 2026, 15:10Uthra Sundaram: Honouring Donors During International Plasma Awareness Week
-
Oct 7, 2026, 15:04Daniel Victor Ortigoza: Should Frail Older Patients With AF Switch From VKA to DOACs?
-
Oct 7, 2026, 14:53Susan Noone: Donor Turned Recipient Shares Lifesaving Transfusion Story